Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Zika Virus Therapeutics Market: By Product: Acetaminophen, Other NSAIDs; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; SWOT Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments

Global Zika Virus Therapeutics Market Outlook

The global zika virus therapeutics market stood at a value of around USD 16.72 billion in 2020. The industry is further projected to grow at a CAGR of 5.6% over the forecast period of 2021-2026 to attain USD 21.57 billion by 2026.

 

Global Zika Virus Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The global zika virus therapeutic market is being driven by the rising demand to prevent the virus from spreading, rapid technological advancements leading to the development of vaccines to fight it, along with the increased R&D in the field of zika virus RNA treatment.

 

Properties and Applications

Zika virus infection is triggered by an Aedes mosquito-borne virus that bites during the day. In general, the symptoms include fever, rash, conjunctivitis, muscle and joint pain, malaise, or headache.

 

Global Zika Virus Therapeutics Market By Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on the product type, the industry can be segmented into:

  • Acetaminophen
  • Other NSAIDs

The EMR report further looks into the regional zika virus therapeutics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Zika Virus Therapeutics Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The global zika virus therapeutics market is being supported by the growing incidences of zika virus infection, which is gradually reaching epidemic proportions throughout the world. Zika virus infection have the ability to affect both adults and foetuses in the form of different clinical manifestations such as low-grade fever combined with arthralgia, conjunctivitis, pruritic maculopapular rashes, optic neuropathy, microcephalus, and congenital glaucoma. Especially in Latin America and the Caribbean, the number of instances of zika virus infection and related comorbidities is anticipated to increase considerably, leading to the growth of zika virus therapeutics market in the region and further aiding the global industry growth. The need to prevent and treat zika-related congenital disabilities and the development of the latest vaccines to prevent the further spread of the virus is aiding the growth of the industry globally. North America is anticipated to dominate the global zika virus therapeutics market over the forecast period. Within North America, the U.S. holds the most extensive industry-sponsored clinical trials.


 
Competitive Landscape

The report presents a detailed analysis of the following key players in the global zika virus therapeutics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Aurobindo Pharma Ltd.
  • Johnson & Johnson Services, Inc.
  • Perrigo Co. Plc
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Region
Breakup by Product Acetaminophen, Other NSAIDs
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Aurobindo Pharma Ltd., Johnson & Johnson Services, Inc., Perrigo Co. Plc, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Cost Structure
    4.5    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraint Analysis
    5.3    Industry Challenges
    5.4    Industry Opportunities
6    Global Zika Virus Therapeutics Market Analysis
    6.1    Global Zika Virus Therapeutics Market (2016-2020) & Forecast (2021-2026)
    6.2    Global Zika Virus Therapeutics Market Breakup by Product 
        6.2.1    Acetaminophen
        6.2.2    Other NSAIDs
    6.3     Global Zika Virus Therapeutics Market Breakup by Product: Historical Market (2016-2020) & Forecast (2021-2026)
        6.3.1    Acetaminophen
        6.3.2    Other NSAIDs
    6.4    Global Zika Virus Therapeutics Market Breakup by Region
        6.4.1    North America
            6.4.1.1    United States of America
            6.4.1.2    Canada
        6.4.2    Europe
            6.4.2.1    Germany
            6.4.2.2    United Kingdom
            6.4.2.3    France
            6.4.2.4    Italy
            6.4.2.5    Others
        6.4.3    Asia Pacific
            6.4.3.1    China
            6.4.3.2    Japan
            6.4.3.3    India
            6.4.3.4    ASEAN
            6.4.3.5    Others
        6.4.4    Latin America
            6.4.4.1    Brazil
            6.4.4.2    Argentina
            6.4.4.3    Mexico
            6.4.4.4    Others
        6.4.5    Middle East & Africa
            6.4.5.1    Saudi Arabia
            6.4.5.2    United Arab Emirates
            6.4.5.3    Nigeria
            6.4.5.4    South Africa
            6.4.5.5    Others
    6.5    Global Zika Virus Therapeutics Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        6.5.1    North America
            6.5.1.1    United States of America
            6.5.1.2    Canada
        6.5.2    Europe
            6.5.2.1    Germany
            6.5.2.2    United Kingdom
            6.5.2.3    France
            6.5.2.4    Italy
            6.5.2.5    Others
        6.5.3    Asia Pacific
            6.5.3.1    China
            6.5.3.2    Japan
            6.5.3.3    India
            6.5.3.4    ASEAN
            6.5.3.5    Others
        6.5.4    Latin America
            6.5.4.1    Brazil
            6.5.4.2    Argentina
            6.5.4.3    Mexico
            6.5.4.4    Others
        6.5.5    Middle East & Africa
            6.5.5.1    Saudi Arabia
            6.5.5.2    United Arab Emirates
            6.5.5.3    Nigeria
            6.5.5.4    South Africa
            6.5.5.5    Others
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    Competitive Landscape & Supplier Analysis 
    9.1    Aurobindo Pharma Ltd.
        9.1.1    Company Overview
        9.1.2    Financial Analysis
    9.2    Johnson & Johnson Services, Inc.
        9.2.1    Company Overview
        9.2.2    Financial Analysis         
    9.3    Perrigo Co. Plc
        9.3.1    Company Overview
        9.3.2    Financial Analysis              
    9.4    Sun Pharmaceutical Industries Ltd.
        9.4.1    Company Overview
        9.4.2    Financial Analysis     
    9.5    Takeda Pharmaceutical Company Limited
        9.5.1    Company Overview
        9.5.2    Financial Analysis          
    9.6    Others
10    Industry Events and Developments

Key Questions Answered in the Report

In 2020, the global zika virus therapeutics market attained a value of nearly USD 16.72 billion.

The market is projected to grow at a CAGR of 5.6% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach USD 21.57 billion by 2026.

The major drivers of the market include growing incidences of zika virus infection and development of vaccines.

Increasing research and development and technological advancements are the key industry trend propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with the North America accounting for the largest market share.

The different product types include acetaminophen and other NSAIDs.

The major players in the industry are Aurobindo Pharma Ltd., Johnson & Johnson Services, Inc., Perrigo Co. Plc, Sun Pharmaceutical Industries Ltd., and Takeda Pharmaceutical Company Limited, among others.

Analyst Review

The global zika virus therapeutics market attained a value of USD 16.72 billion in 2020, driven by the rising zika virus infections. Aided by the growing technological advancements, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 5.6%. The market is projected to reach USD 21.57 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product types, the zika virus therapeutics industry can be segmented into acetaminophen and other NSAIDs. The major regional markets for zika virus therapeutics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. Among these, North America has the largest market share. The key players in the above market include Aurobindo Pharma Ltd., Johnson & Johnson Services, Inc., Perrigo Co. Plc, Sun Pharmaceutical Industries Ltd., and Takeda Pharmaceutical Company Limited, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER